Molecular Pathways: Dietary Regulation of Stemness and Tumor Initiation by the PPAR-δ Pathway

被引:37
作者
Beyaz, Semir [1 ,2 ,3 ,4 ]
Yilmaz, Omer H. [1 ,2 ,5 ,6 ]
机构
[1] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[2] MIT, Dept Biol, Cambridge, MA USA
[3] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA
[4] Harvard Med Sch, Harvard Stem Cell Inst, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA
[5] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[6] Harvard Med Sch, Boston, MA USA
关键词
ACTIVATED-RECEPTOR-DELTA; ACID-BINDING PROTEIN; PROLIFERATOR; BETA/DELTA; AGONIST; METABOLISM; POLYMORPHISMS; ADIPOSE; CANCER; CELLS;
D O I
10.1158/1078-0432.CCR-16-0775
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Peroxisome proliferator-activated receptor delta (PPAR-delta) is a nuclear receptor transcription factor that regulates gene expression during development and disease states, such as cancer. However, the precise role of PPAR-delta during tumorigenesis is not well understood. Recent data suggest that PPAR-delta may have context-specific oncogenic and tumor-suppressive roles depending on the tissue, cell-type, or diet-induced physiology in question. For example, in the intestine, pro-obesity diets, such as a high-fat diet (HFD), are associated with increased colorectal cancer incidence. Interestingly, many of the effects of an HFD in the stem and progenitor cell compartment are driven by a robust PPAR-delta program and contribute to the early steps of intestinal tumorigenesis. Importantly, the PPAR-delta pathway or its downstream mediators may serve as therapeutic intervention points or biomarkers in colon cancer that arise in patients who are obese. Although potent PPAR-delta agonists and antagonists exist, their clinical utility may be enhanced by uncovering how PPAR-delta mediates tumorigenesis in diverse tissues and cell types as well as in response to diet. (C) 2016 AACR.
引用
收藏
页码:5636 / 5641
页数:6
相关论文
共 60 条
  • [1] Genomewide Analyses Define Different Modes of Transcriptional Regulation by Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ)
    Adhikary, Till
    Kaddatz, Kerstin
    Finkernagel, Florian
    Schoenbauer, Anne
    Meissner, Wolfgang
    Scharfe, Maren
    Jarek, Michael
    Bloecker, Helmut
    Mueller-Bruesselbach, Sabine
    Mueller, Rolf
    [J]. PLOS ONE, 2011, 6 (01):
  • [2] Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes -: The STOP-NIDDM trial
    Andrulionyte, Laura
    Peltola, Paula
    Chiasson, Jean-Louis
    Laakso, Markku
    [J]. DIABETES, 2006, 55 (07) : 2148 - 2152
  • [3] Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer
    Barak, Y
    Liao, D
    He, WM
    Ong, ES
    Nelson, MC
    Olefsky, JM
    Boland, R
    Evans, RM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) : 303 - 308
  • [4] The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1
    Barroso, Emma
    Eyre, Elena
    Palomer, Xavier
    Vazquez-Carrera, Manuel
    [J]. BIOCHEMICAL PHARMACOLOGY, 2011, 81 (04) : 534 - 543
  • [5] Alterations of peroxisome proliferator-activated receptor δ activity affect fatty acid-controlled adipose differentiation
    Bastie, C
    Luquet, S
    Holst, D
    Jehl-Pietri, C
    Grimaldi, PA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (49) : 38768 - 38773
  • [6] MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
    Bays, Harold E.
    Schwartz, Sherwyn
    Littlejohn, Thomas, III
    Kerzner, Boris
    Krauss, Ronald M.
    Karpf, David B.
    Choi, Yun-Jung
    Wang, Xueyan
    Naim, Sue
    Roberts, Brian K.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (09) : 2889 - 2897
  • [7] High-fat diet enhances stemness and tumorigenicity of intestinal progenitors
    Beyaz, Semir
    Mana, Miyeko D.
    Roper, Jatin
    Kedrin, Dmitriy
    Saadatpour, Assieh
    Hong, Sue Jean
    Bauer-Rowe, Khristian E.
    Xifaras, Michael E.
    Akkad, Adam
    Arias, Erika
    Pinello, Luca
    Katz, Yarden
    Shinagare, Shweta
    Abu-Remaileh, Monther
    Mihaylova, Maria M.
    Lamming, Dudley W.
    Dogum, Rizkullah
    Guo, Guoji
    Bell, George W.
    Selig, Martin
    Nielsen, G. Petur
    Gupta, Nitin
    Ferrone, Cristina R.
    Deshpande, Vikram
    Yuan, Guo-Cheng
    Orkin, Stuart H.
    Sabatini, David M.
    Yilmaz, Oemer H.
    [J]. NATURE, 2016, 531 (7592) : 53 - +
  • [8] Ligand activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) inhibits chemically induced skin tumorigenesis
    Bility, Moses T.
    Devlin-Durante, Meghann K.
    Blazanin, Nicholas
    Glick, Adam B.
    Ward, Jerrold M.
    Kang, Boo Hyon
    Kennett, Mary J.
    Gonzalez, Frank J.
    Peters, Jeffrey M.
    [J]. CARCINOGENESIS, 2008, 29 (12) : 2406 - 2414
  • [9] Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia
    Choi, Yun-Jung
    Roberts, Brian K.
    Wang, Xueyan
    Geaney, J. Casey
    Naim, Sue
    Wojnoonski, Kathleen
    Karpf, David B.
    Krauss, Ronald M.
    [J]. ATHEROSCLEROSIS, 2012, 220 (02) : 470 - 476
  • [10] PPARβ/δ Activation Induces Enteroendocrine L Cell GLP-1 Production
    Daoudi, Mehdi
    Hennuyer, Nathalie
    Borland, Michael G.
    Touche, Veronique
    Duhem, Christian
    Gross, Barbara
    Caiazzo, Robert
    Kerr-Conte, Julie
    Pattou, Francois
    Peters, Jeffrey M.
    Staels, Bart
    Lestavel, Sophie
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : 1564 - 1574